Medicine and Dentistry
X Linked Hypophosphatemic Rickets
100%
Vitamin D
56%
Hypophosphatemic Rickets
51%
Rickets
48%
Prevalence
33%
Combination Therapy
33%
Burosumab
30%
Disease
28%
Quality of Life
22%
Systematic Review
20%
Chronic Disease
20%
Cohort Analysis
20%
Denosumab
19%
Interim Analysis
19%
Pediatrics
17%
Fibroblast Growth Factor 23
16%
Randomized Controlled Trial
15%
Leg
15%
Hypovitaminosis D
15%
25 Hydroxyvitamin D
14%
Bone Mineral
14%
Adolescent
14%
Bone Density
13%
Observational Study
13%
Epileptic Seizure
12%
Vitamin D Deficiency
11%
Medical Record
11%
Alfacalcidol
10%
Thyroid Disease
10%
Mental Health
10%
Symptom
10%
Cross Sectional Study
10%
Spontaneous Abortion
9%
Lung Dysplasia
9%
Osteoclast Differentiation Factor
9%
Tricho-Rhino-Phalangeal Syndrome
9%
Sacrum
9%
Zoledronic Acid
9%
Pycnodysostosis
9%
Surgery
9%
Fetus Lung Maturation
9%
Osteogenesis Imperfecta
9%
Oxygenase
9%
Von Hippel-Lindau Disease
9%
Bone Strength
9%
First Trimester Pregnancy
9%
Osteoclastoma
9%
Child
9%
Survival Time
9%
Oxygen Saturation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin D
55%
Rickets
36%
Hypophosphatemic Rickets
30%
X-Linked Hypophosphatemia
29%
Hypovitaminosis D
22%
Combination Therapy
22%
Cohort Study
20%
Disease
19%
Burosumab
19%
Denosumab
19%
Prevalence
19%
25 Hydroxyvitamin D
12%
Randomized Controlled Trial
11%
Lung Dysplasia
9%
Zoledronic Acid
9%
Thyroid Disease
9%
Tablet
9%
Inflammatory Bowel Disease
9%
Chronic Disease
9%
Osteoclastoma
9%
Oxygenase
9%
Survival Time
9%
Vitamin D Deficiency
9%
Osteoclast Differentiation Factor
9%
Graves Disease
8%
Respiratory Distress Syndrome
8%
Alfacalcidol
8%
Hashimoto Disease
7%
Neoplasm
6%
Side Effect
6%
Surfactant
6%
Symptom
5%
Biochemistry, Genetics and Molecular Biology
X-Linked Hypophosphatemia
48%
Vitamin D
24%
Genetics
19%
Rickets
13%
Hypovitaminosis D
11%
Fibroblast Growth Factor 23
10%
Cohort Study
9%
Tricho-Rhino-Phalangeal Syndrome Type 1
9%
Progeny
9%
Bone Development
9%
Craniofacial Morphology
9%
CLCN5
9%
Survival Time
9%
Lung Weight
9%
Oxygenase
9%
Oxygen Saturation
9%
Leg Length
9%
Body Weight
9%
Sclerostin
9%
Bone Remodeling
9%
Prevalence
5%